C60 fullerene accumulation in human leukemic cells and perspectives of LED-mediated photodynamic therapy
Anna GrebinykDivision Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany; Dept. of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany; Educational and Scientific Center "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, UkraineSergii GrebinykDivision Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, GermanySvitlana PrylutskaDept. of Chemistry, Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, UkraineUwe RitterInstitute of Chemistry and Biotechnology, University of Technology Ilmenau, Weimarer Straße 25 (Curiebau), 98693 Ilmenau, GermanyOlga MatyshevskaEducational and Scientific Center "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601 Kyiv, UkraineThomas DandekarDept. of Bioinformatics, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, GermanyMarcus FrohmeDivision Molecular Biotechnology and Functional Genomics, Technical University of Applied Sciences Wildau, Hochschulring 1, 15745 Wildau, Germany. Electronic address: [email protected]
2018en
ABI
Аннотация
Recent progress in nanobiotechnology has attracted interest to a biomedical application of the carbon nanostructure C 60 fullerene since it possesses a unique structure and versatile biological activity. C 60 fullerene potential application in the frame of cancer photodynamic therapy (PDT) relies on rapid development of new light sources as well as on better understanding of the fullerene interaction with cells.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0